Hajime Yamazaki
Overview
Explore the profile of Hajime Yamazaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
172
Citations
1637
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Okada H, Uza N, Matsumori T, Yamazaki H, Yasuda M, Kuwada T, et al.
Gut Liver
. 2025 Jan;
19(1):136-144.
PMID: 39778881
Background/aims: Pathological evaluation is crucial for diagnosing biliary lesions and determining appropriate treatment strategies. However, tissue sampling via the transpapillary route can be difficult. In this study, we aimed to...
2.
Okabe M, Yamamoto S, Shiokawa M, Hisamatsu T, Yamazaki H, Nakanishi R, et al.
J Gastroenterol
. 2024 Dec;
60(2):263-264.
PMID: 39729094
No abstract available.
3.
Kurihara I, Yamazaki H, Kato S, Oyama-Manabe N, Sugawara H
BMC Infect Dis
. 2024 Dec;
24(1):1437.
PMID: 39696050
Background: The spleen is a key organ in preventing pneumococcal infection, especially in patients with immunocompromised condition such as those with cancer. Previous studies have shown that a small spleen...
4.
Kugiyama N, Nagaoka K, Yamada R, Watanabe T, Yamazaki H, Ushijima S, et al.
J Gastroenterol
. 2024 Dec;
PMID: 39661112
Background: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a poor prognosis. Mac2-binding protein glycosylated isomer (M2BPGi), a known biomarker for liver fibrosis, is also elevated in other fibrotic...
5.
Nakanishi R, Kuwada T, Shiokawa M, Nishikawa Y, Ota S, Yamazaki H, et al.
Inflamm Bowel Dis
. 2024 Dec;
31(3):777-785.
PMID: 39657162
Background: Pouchitis is the most common complication of restorative proctocolectomy (RPC) with ileal pouch-anal anastomosis (IPAA) in patients with ulcerative colitis (UC). We previously reported the presence of anti-integrin αvβ6...
6.
Okabayashi S, Itaya T, Yamazaki H, Yanai R, Isshiki M, Yamamoto Y
J Gastroenterol
. 2024 Dec;
60(3):285-293.
PMID: 39636325
Background: The safety profile of high doses of tumour necrosis factor inhibitors (TNFi) therapy for cancer risk in immune-mediated inflammatory diseases (IMIDs) remains uncertain. We evaluated the risk of cancer...
7.
Yamazaki H, Streicher S, Wu L, Fukuhara S, Wagner R, Heni M, et al.
Cell Rep Med
. 2024 Dec;
5(12):101842.
PMID: 39631403
No abstract available.
8.
Okabe M, Yamamoto S, Shiokawa M, Hisamatsu T, Yamazaki H, Nakanishi R, et al.
J Gastroenterol
. 2024 Nov;
60(1):86-95.
PMID: 39607498
Background: A serum biomarker for diagnosing ulcerative colitis (UC) remains to be established. Although we recently reported an anti-integrin αvβ6 antibody (V6 Ab) for diagnosing UC with high sensitivity and...
9.
Yamazaki H, Heni M, Wagner R, Huang B
Am J Gastroenterol
. 2024 Nov;
PMID: 39564999
No abstract available.
10.
Morikubo H, Nagahama T, Nagai K, Yamazaki H, Kobayashi T
Inflamm Intest Dis
. 2024 Nov;
9(1):260-270.
PMID: 39563684
Introduction: There is a close relationship between the relapse of inflammatory bowel disease (IBD) and lifestyle factors, including concomitant medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), antithrombotic drugs, smoking status,...